Insider Trading March 17, 2026

Scientific Industries chairman makes modest share purchase amid audit overhaul

John A. Moore buys 1,000 shares as company institutes new independent auditor following a brief prior engagement

By Priya Menon SCND
Scientific Industries chairman makes modest share purchase amid audit overhaul
SCND

John A. Moore, chairman of Scientific Industries INC (NASDAQ: SCND), bought 1,000 common shares on February 19, 2026, for $0.65 each, a $650 purchase. The transaction comes while the stock is up 32% year-to-date but reportedly still below a cited purchase price of $0.74. The company recently replaced its auditor after an interim period of engagement and asset transfers between accounting firms.

Key Points

  • John A. Moore purchased 1,000 shares of Scientific Industries on February 19, 2026, at $0.65 per share, totaling $650.
  • After the transaction, Moore's direct ownership in the company stands at 917,871 shares; the stock is noted as up 32% year-to-date while trading below a cited price of $0.74.
  • Scientific Industries replaced its independent auditor with Carr, Riggs & Ingram, LLC after CRI acquired certain capital markets assets from prior auditor Berkowitz Pollack Brant Advisors + CPAs, LLP; the Audit Committee dismissed BPB and approved CRI on January 14, 2026.

John A. Moore, who serves as Chairman of the Board at Scientific Industries INC (NASDAQ: SCND), acquired 1,000 shares of the company’s common stock on February 19, 2026, at $0.65 per share. The total cash outlay for the purchase was $650.

The purchase arrives amid recent share-price movement that has seen the stock rise 32% year-to-date. The company’s shares were noted as trading below a cited purchase price of $0.74. InvestingPro analysis lists Scientific Industries’ market capitalization at $8.83 million and characterizes that market cap as appearing undervalued.

Following the February 19 transaction, Moore is reported to hold 917,871 shares of Scientific Industries directly.

Separately, InvestingPro references 11 additional ProTips for SCND and offers a Pro Research Report covering this company along with over 1,400 other U.S. equities.


Scientific Industries has also made changes to its external audit arrangements. The company appointed Carr, Riggs & Ingram, LLC (CRI) as its new independent registered public accounting firm. That appointment followed CRI’s acquisition of certain assets from the capital markets practice of Scientific Industries’ prior auditor, Berkowitz Pollack Brant Advisors + CPAs, LLP (BPB), effective January 1, 2026.

The Audit Committee of Scientific Industries’ Board of Directors dismissed BPB and approved CRI’s appointment on January 14, 2026. BPB had been listed as the company’s independent auditor from August 22, 2025, to December 31, 2025; during that interval BPB did not issue any reports on the company’s interim or annual consolidated financial statements. Company materials describe these actions as part of recent changes in the firm’s auditing processes.


The transaction by the chairman and the auditor transition are distinct developments disclosed by the company. The share purchase represents a relatively small, direct acquisition by an insider. The auditor change reflects a shift in the independent accounting firm responsible for registered public-company audit services following an asset transfer and a brief prior auditor engagement.

Risks

  • Audit transition and the prior auditor’s lack of issued reports for the stated interim period introduce uncertainty regarding recent audit continuity and oversight - this affects accounting, auditing, and investor confidence in small-cap public companies.
  • The chairman’s small-dollar purchase may have limited informational value regarding management’s broader conviction given the modest size relative to total holdings and company market capitalization - this is relevant to equity investors and small-cap market participants.
  • Discrepancies in reported price references (purchase at $0.65 versus a cited purchase-price figure of $0.74) indicate potential confusion in reported pricing context and could complicate interpretation of insider transaction metrics - relevant to market analysts and regulatory reporting observers.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026